Dana Hong
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 408 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 408 payments — averaging $26.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Regeneron Healthcare Solutions, Inc.$524
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$516
- Madrigal Pharmaceuticals$512
- plus $4K from 26 others
What the payments were for
- Food & beverage$10,798100%
- Education$330%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 101 | $1,931 |
| Johnson & Johnson | 40 | $1,562 |
| Takeda Pharmaceuticals U.S.A., Inc. | 45 | $1,319 |
| Regeneron Healthcare Solutions, Inc. | 17 | $524 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 31 | $516 |
| Madrigal Pharmaceuticals | 17 | $512 |
| Phathom Pharmaceuticals, Inc. | 9 | $447 |
| Insmed, Inc. | 14 | $404 |
| Astellas Pharma US Inc | 13 | $399 |
| Celltrion USA Inc. | 16 | $388 |
| Boehringer Ingelheim | 8 | $331 |
| Sanofi | 9 | $258 |
| Lilly USA, LLC | 12 | $252 |
| Grifols USA, LLC | 10 | $240 |
| QOL Medical, LLC | 8 | $207 |
| Redhill Biopharma Inc. | 8 | $176 |
| Ardelyx, Inc. | 6 | $167 |
| E.r. Squibb & Sons, L.L.C. | 1 | $124 |
| Novo Nordisk | 7 | $123 |
| Sanofi-aventis U.S. LLC | 1 | $122 |
| Veloxis Pharmaceuticals, Inc. | 1 | $122 |
| Braintree Laboratories, Inc. | 6 | $121 |
| Vivus LLC | 6 | $118 |
| Pfizer | 5 | $99 |
| Aimmune Therapeutics, Inc. | 4 | $83 |
| Advanced Respiratory, Inc | 3 | $72 |
| Ipsen Biopharmaceuticals, Inc | 3 | $54 |
| Biocon Biologics Inc | 2 | $41 |
| Evoke Pharma, Inc. | 2 | $38 |
| Janssen Scientific Affairs, LLC | 1 | $36 |
| Baxter Healthcare | 1 | $32 |
| Gilead | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$617
- STELARA$370
- VOQUEZNA$339
- Skyrizi$250
- REZDIFFRA$246
- CRESEMBA$124
- THYMOGLOBULIN$122
- Envarsus$122
- LIVTENCITY$118
- ZYMFENTRA$109
How this compares
$10,831 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Other family in Katy
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.